The shareholder will receive:
 |
|
 |
 |
Gift box |
Share certificate |
Rights & perks |
Annual reports |
You can now give the gift of share ownership to a fan of
Lexicon Genetics Inc
so they can own a piece of the company. They will receive an exclusive shareholder gift box as detailed below.
Enclosed in the exclusive shareholder gift box is:
- A shareholder
introductory
letter
- A
presentation certificate
(with a space to write the shareholders name)
- A shareholder registration sheet
- Details on how to register the share in the shareholder’s name
- An explanation of common
shareholder rights and terms
- A
information sheet
Once the share is registered a genuine
Lexicon Genetics Inc
share certificate displaying the shareholder's name will be delivered. The shareholder will be entitled to shareholder rights and any perks relevant to one share. The shareholder will also receive important information directly from
Lexicon Genetics Inc
including annual reports, invitations to meetings and a right to vote on issues affecting the company.
The gift box is usually despatched within 24 hours (Mon-Fri) and can either be delivered directly to you or to the shareholder to be.
The gift box includes:
.
|
|
|
|
|
|
Glossy gift box |
Welcome letter |
Presentation
certificate |
Shareholder
registration sheet |
Shareholder
booklet |
Info sheet |
The shareholder will also receive the shareholder perks detailed below:
Invitation to shareholder AGM when held.
Please note all perks are subject to change at the company's discretion without notice.
Important:
• The genuine
Lexicon Genetics Inc
share certificate will be delivered separately from the gift box once issued from the stock market.
• All correspondence will come directly from
Lexicon Genetics Inc
once the share certificate is delivered. This is because the share certificate is registered in your name or the name of a friend if you want to make this a gift.
• The total price includes all registration fees and the
Lexicon Genetics Inc
share price.
Company Information:
Lexicon Genetics Incorporated is a biopharmaceutical company focused on the discovery of treatments for human disease. The Company is using gene-knockout technology to systematically discover in living mammals (in-vivo) the physiological functions and pharmaceutical utility of genes. Lexicon's gene function discoveries fuel therapeutic discovery programs in diabetes, obesity, cardiovascular disease, immune disorders, neurological disease and cancer. The Company has established drug discovery alliances and functional genomics collaborations with pharmaceutical and biotechnology companies, research institutes and academic institutions worldwide to commercialize its technology and turn its discoveries into drugs. As of March 10, 2003, the Company had advanced more than 15 in-vivo, validated drug targets into therapeutic discovery programs. |
VIEW BASKET 
